Delayed Rod-Mediated Dark Adaptation Linked With Doubled Risk of AMD

 

Patients with delayed rod-mediated dark adaptation were nearly twice as likely as patients with normal dark adaptation to develop AMD by 3 years after initial testing, according to a study published in Ophthalmology.1

Baseline and follow-up visits were completed by 325 patients with stage 1 normal vision as defined by the AREDS AMD classification system. Approximately 81% of participants had normal rod-mediated dark adaptation.

After adjusting for age and smoking status, patients with rod-mediated abnormal dark adaptation were approximately twice as likely to have AMD at follow-up year 3 compared with patients with normal rod-mediated dark adaptation.

“The biological relevance of this test is high,” the study authors wrote, “because it assesses translocation of vitamin A derivatives across the retinal pigment epithelium and Bruch’s membrane, two tissues with prominent age- and AMD-related pathology.”

1. Owsley C, McGwin G, Clark ME, et al. Delayed rod-mediated dark adaptation is a functional biomarker for incident early age-related macular degeneration [published online ahead of print October 30, 2015]. Ophthalmology.

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman
Editor-in-Chief
484-581-1827
kroman@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.